| abstract |
The invention provides specific imidazopyrazines and their pharmaceutical compositions. Methods are proposed for treating patients suffering from certain diseases and disorders sensitive to suppressing Syk activity, including administering to these patients an amount of at least one chemical compound effective to alleviate the signs or symptoms of the disease or disorder. Methods are also proposed for determining the presence or absence of Syk-kinase in a sample. |